The potential therapy with dental tissue-derived mesenchymal stem cells in Parkinson’s disease
Abstract Parkinson’s disease (PD), the second most common neurodegenerative disease worldwide, is caused by the loss of dopaminergic (DAergic) neurons in the substantia nigra resulting in a series of motor or non-motor disorders. Current treatment methods are unable to stop the progression of PD and...
Main Authors: | Zhuangzhuang Xiao, Tong Lei, Yanyan Liu, Yanjie Yang, Wangyu Bi, Hongwu Du |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-020-01957-4 |
Similar Items
-
Dental stem cells: Dentinogenic, osteogenic, and neurogenic differentiation and its clinical cell based therapies
by: Gurlal Singh Brar, et al.
Published: (2012-01-01) -
Dental Pulp-Derived Mesenchymal Stem Cells for Modeling Genetic Disorders
by: Keiji Masuda, et al.
Published: (2021-02-01) -
SHED - Basic Structure for Stem Cell Research
by: Rucha Kashyap
Published: (2015-03-01) -
Characteristics and Therapeutic Potential of Dental Pulp Stem Cells on Neurodegenerative Diseases
by: Tomoyuki Ueda, et al.
Published: (2020-05-01) -
A prospective Saudi dental stem-cell bank from the perspective of the public and dental practitioners: A cross sectional survey
by: Rasha K Alomar, et al.
Published: (2020-01-01)